Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells

Abstract While surgical resection combined with temozolomide (TMZ) chemotherapy remains the cornerstone of glioma treatment, therapeutic efficacy is significantly limited by intrinsic and acquired TMZ resistance. This study identified elevated expression of circular RNA circ0059511 in TMZ-resistant...

Full description

Saved in:
Bibliographic Details
Main Authors: Yiming Chen, Pingxin Cheng, Wei Huang, Yajun Jing, Jinye Su, Zanyi Wu, Jiawei Cai
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-12492-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849344312916049920
author Yiming Chen
Pingxin Cheng
Wei Huang
Yajun Jing
Jinye Su
Zanyi Wu
Jiawei Cai
author_facet Yiming Chen
Pingxin Cheng
Wei Huang
Yajun Jing
Jinye Su
Zanyi Wu
Jiawei Cai
author_sort Yiming Chen
collection DOAJ
description Abstract While surgical resection combined with temozolomide (TMZ) chemotherapy remains the cornerstone of glioma treatment, therapeutic efficacy is significantly limited by intrinsic and acquired TMZ resistance. This study identified elevated expression of circular RNA circ0059511 in TMZ-resistant glioblastoma tissues and delineated its mechanistic role in chemoresistance. Circ0059511 silencing suppressed glioma cell proliferation, clonogenicity, and metastatic potential, as confirmed by Western blotting. These findings were corroborated in subcutaneous xenograft models, where circ0059511 silencing combined with TMZ reduced tumor volume. Mechanistically, circ0059511 functions as a competitive endogenous RNA that sequesters miR-194-5p, thereby derepressing FZD6 translation to sustain chemoresistance. Rescue experiments established the hierarchical regulatory axis: miR-194-5p inhibition and FZD6 ablation partially reversed the TMZ-sensitizing effects of circ0059511 knockdown. Our work unveils the circ0059511/miR-194-5p/FZD6 axis as a central mediator of TMZ resistance in glioblastoma, providing a rationale for combinatorial therapeutic strategies to overcome chemoresistance.
format Article
id doaj-art-fcaee2b04b8f46d79e092529db5579d4
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-fcaee2b04b8f46d79e092529db5579d42025-08-20T03:42:41ZengNature PortfolioScientific Reports2045-23222025-07-0115111310.1038/s41598-025-12492-8Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cellsYiming Chen0Pingxin Cheng1Wei Huang2Yajun Jing3Jinye Su4Zanyi Wu5Jiawei Cai6Department of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical UniversityDepartment of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical UniversityDepartment of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical UniversityDepartment of Neurosurgery, The First Affiliated Hospital, Fujian Medical UniversityDepartment of Neurosurgery, The First Affiliated Hospital, Fujian Medical UniversityDepartment of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical UniversityDepartment of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical UniversityAbstract While surgical resection combined with temozolomide (TMZ) chemotherapy remains the cornerstone of glioma treatment, therapeutic efficacy is significantly limited by intrinsic and acquired TMZ resistance. This study identified elevated expression of circular RNA circ0059511 in TMZ-resistant glioblastoma tissues and delineated its mechanistic role in chemoresistance. Circ0059511 silencing suppressed glioma cell proliferation, clonogenicity, and metastatic potential, as confirmed by Western blotting. These findings were corroborated in subcutaneous xenograft models, where circ0059511 silencing combined with TMZ reduced tumor volume. Mechanistically, circ0059511 functions as a competitive endogenous RNA that sequesters miR-194-5p, thereby derepressing FZD6 translation to sustain chemoresistance. Rescue experiments established the hierarchical regulatory axis: miR-194-5p inhibition and FZD6 ablation partially reversed the TMZ-sensitizing effects of circ0059511 knockdown. Our work unveils the circ0059511/miR-194-5p/FZD6 axis as a central mediator of TMZ resistance in glioblastoma, providing a rationale for combinatorial therapeutic strategies to overcome chemoresistance.https://doi.org/10.1038/s41598-025-12492-8circ0059511GlioblastomamiR-194-5pTemozolomide resistance
spellingShingle Yiming Chen
Pingxin Cheng
Wei Huang
Yajun Jing
Jinye Su
Zanyi Wu
Jiawei Cai
Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells
Scientific Reports
circ0059511
Glioblastoma
miR-194-5p
Temozolomide resistance
title Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells
title_full Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells
title_fullStr Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells
title_full_unstemmed Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells
title_short Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells
title_sort association of hsa circ 0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells
topic circ0059511
Glioblastoma
miR-194-5p
Temozolomide resistance
url https://doi.org/10.1038/s41598-025-12492-8
work_keys_str_mv AT yimingchen associationofhsacirc0059511withthesensitivityofthetemozolomidechemotherapeutictreatmentinhumangliomacells
AT pingxincheng associationofhsacirc0059511withthesensitivityofthetemozolomidechemotherapeutictreatmentinhumangliomacells
AT weihuang associationofhsacirc0059511withthesensitivityofthetemozolomidechemotherapeutictreatmentinhumangliomacells
AT yajunjing associationofhsacirc0059511withthesensitivityofthetemozolomidechemotherapeutictreatmentinhumangliomacells
AT jinyesu associationofhsacirc0059511withthesensitivityofthetemozolomidechemotherapeutictreatmentinhumangliomacells
AT zanyiwu associationofhsacirc0059511withthesensitivityofthetemozolomidechemotherapeutictreatmentinhumangliomacells
AT jiaweicai associationofhsacirc0059511withthesensitivityofthetemozolomidechemotherapeutictreatmentinhumangliomacells